Tag: Heart / Stroke-Related: High Blood Pressure
Lorundrostat Effective for Lowering BP in Uncontrolled Hypertension
Changes in office systolic BP of −14.1, −13.2, −6.9, and −4.1 mm Hg seen with 100, 50, 12.5 mg once daily of lorundrostat and placebo
Hypertension, Statin Use Increased for Individuals Using TAF for PrEP
Incident hypertension, statin use higher with tenofovir alafenamide fumarate compared with tenofovir disoproxil fumarate
Risk for Dementia Reduced in Association With Antihypertensive Use
Individual patient data meta-analysis shows increased risk for dementia for those with untreated hypertension
Seasonal Difference Observed in Systolic Blood Pressure
Seasonal variation of 1.4 mm Hg tied to nearly 5 percent variation in blood pressure control
Hypertension While Lying Down Tied to Worse Cardiovascular Disease Outcomes
Findings seen regardless of whether hypertension persists in seated position
Hypertension, Anemia Contribute to Racial Disparities in Severe Maternal Morbidity
Population attributable risk percentage for antepartum anemia and SMM highest for multiracial, Black, Hispanic patients
Fresh Produce Rx Tied to Improvements in Food Security, Cardiometabolic Outcomes
Clinically relevant improvements seen in glycated hemoglobin, blood pressure, and BMI for adults
Incidence of New-Onset HTN Higher for COVID-19 Versus Influenza Patients
Hospitalized and nonhospitalized patients with COVID-19 more likely to develop persistent HTN than those with influenza
Younger Kidney Cancer Patients on VEGF Inhibitors at Elevated Risk for Hypertension
Vascular endothelial growth factor inhibitors tied to hypertension among people aged 18 to 39 years being treated for renal cancer
Intensive Inpatient BP Management Not Beneficial in Seniors
Risk for adverse events increased with intensive treatment among older adults with elevated BP in first 48 hours of hospitalization